OncomineTM Dx Target Test Multi-CDx system (Thermo Fisher Scientific, USA) revealed that tumor cells harbored an identical EGFR mutation (deletion E746-A750 in exon 19) with a secondary EGFR T790M mutation. The gene discussed is EGFR; the disease is neoplasm.